CCI: quality concerns undermining pharmaceutical competition
Shutterstock/ADragan
A key hurdle to greater price competition for generic drugs in India is consumer concern and information asymmetry about quality, according to a market study conducted by the country’s competition watchdog.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now